136.36
price up icon5.21%   6.75
after-market アフターアワーズ: 136.60 0.24 +0.18%
loading
前日終値:
$129.61
開ける:
$132.62
24時間の取引高:
9.17M
Relative Volume:
1.31
時価総額:
$169.30B
収益:
$29.79B
当期純損益:
$9.22B
株価収益率:
18.55
EPS:
7.3494
ネットキャッシュフロー:
$10.23B
1週間 パフォーマンス:
+7.93%
1か月 パフォーマンス:
+5.57%
6か月 パフォーマンス:
+9.66%
1年 パフォーマンス:
+21.99%
1日の値動き範囲:
Value
$132.00
$136.60
1週間の範囲:
Value
$125.12
$136.60
52週間の値動き範囲:
Value
$107.75
$157.29

Gilead Sciences Inc Stock (GILD) Company Profile

Name
名前
Gilead Sciences Inc
Name
セクター
Healthcare (1094)
Name
電話
(650) 574-3000
Name
住所
333 LAKESIDE DR, FOSTER CITY, CA
Name
職員
17,000
Name
Twitter
@GileadSciences
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, MRK, NVS

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GILD icon
GILD
Gilead Sciences Inc
136.36 160.92B 29.79B 9.22B 10.23B 7.3494
LLY icon
LLY
Lilly Eli Co
1,235.56 1.07T 72.25B 25.28B 10.37B 27.78
JNJ icon
JNJ
Johnson Johnson
267.24 624.26B 96.36B 21.04B 17.80B 8.6488
ABBV icon
ABBV
Abbvie Inc
254.65 450.11B 62.82B 3.60B 19.98B 2.0274
MRK icon
MRK
Merck Co Inc
128.86 313.12B 65.51B 8.93B 14.12B 3.5532
NVS icon
NVS
Novartis Ag Adr
157.03 296.69B 54.66B 13.58B 16.05B 7.0171

Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-10 開始されました Jefferies Buy
2026-02-20 開始されました Barclays Equal Weight
2026-02-11 繰り返されました Needham Buy
2026-01-07 再開されました UBS Buy
2025-11-24 再開されました Truist Buy
2025-11-13 開始されました Scotiabank Sector Outperform
2025-08-19 アップグレード Daiwa Securities Neutral → Outperform
2025-08-08 アップグレード Truist Hold → Buy
2025-07-25 アップグレード Needham Hold → Buy
2025-04-22 再開されました Cantor Fitzgerald Overweight
2025-03-04 繰り返されました Oppenheimer Outperform
2025-02-18 アップグレード Deutsche Bank Hold → Buy
2025-02-13 アップグレード DZ Bank Hold → Buy
2025-01-10 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました BofA Securities Buy
2024-11-15 開始されました Wolfe Research Outperform
2024-11-14 開始されました Citigroup Buy
2024-11-08 ダウングレード Maxim Group Buy → Hold
2024-10-21 アップグレード Leerink Partners Market Perform → Outperform
2024-10-17 開始されました Bernstein Outperform
2024-10-07 アップグレード Wells Fargo Equal Weight → Overweight
2024-07-08 アップグレード Raymond James Mkt Perform → Outperform
2024-05-01 繰り返されました Maxim Group Buy
2024-04-24 アップグレード HSBC Securities Reduce → Hold
2024-02-22 ダウングレード Truist Buy → Hold
2023-11-09 開始されました Deutsche Bank Hold
2023-09-08 アップグレード BofA Securities Neutral → Buy
2023-09-06 開始されました HSBC Securities Reduce
2023-07-24 繰り返されました Barclays Equal Weight
2023-05-16 アップグレード BMO Capital Markets Market Perform → Outperform
2023-04-28 再開されました Piper Sandler Overweight
2023-01-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-12-13 再開されました BofA Securities Neutral
2022-12-09 ダウングレード DZ Bank Buy → Hold
2022-10-31 アップグレード Barclays Underweight → Equal Weight
2022-10-28 繰り返されました BMO Capital Markets Market Perform
2022-10-28 繰り返されました Cowen Outperform
2022-10-28 繰り返されました JP Morgan Overweight
2022-10-28 繰り返されました Jefferies Buy
2022-10-28 アップグレード Piper Sandler Neutral → Overweight
2022-10-28 繰り返されました RBC Capital Mkts Outperform
2022-10-28 アップグレード Truist Hold → Buy
2022-10-28 繰り返されました Wells Fargo Equal Weight
2022-10-04 アップグレード JP Morgan Neutral → Overweight
2022-07-13 開始されました Cantor Fitzgerald Neutral
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-02-28 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-02-02 繰り返されました BMO Capital Markets Outperform
2022-02-02 繰り返されました BofA Securities Neutral
2022-02-02 繰り返されました RBC Capital Mkts Outperform
2022-02-02 繰り返されました Truist Hold
2022-02-02 繰り返されました Wells Fargo Equal Weight
2022-01-28 アップグレード Argus Hold → Buy
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Neutral
2021-11-19 アップグレード BMO Capital Markets Market Perform → Outperform
2021-11-19 再開されました Piper Sandler Neutral
2021-10-20 再開されました Cowen Outperform
2021-07-30 繰り返されました BMO Capital Markets Market Perform
2021-07-30 繰り返されました RBC Capital Mkts Outperform
2021-04-01 アップグレード Bernstein Mkt Perform → Outperform
2021-03-30 アップグレード Redburn Neutral → Buy
2021-01-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2021-01-04 アップグレード Guggenheim Neutral → Buy
2020-11-03 再開されました Morgan Stanley Equal-Weight
2020-10-28 開始されました UBS Neutral
2020-09-30 再開されました Jefferies Buy
2020-09-15 アップグレード Maxim Group Hold → Buy
2020-07-31 繰り返されました Credit Suisse Neutral
2020-07-31 繰り返されました Morgan Stanley Equal-Weight
2020-07-31 繰り返されました Piper Sandler Overweight
2020-07-31 繰り返されました RBC Capital Mkts Outperform
2020-07-31 繰り返されました SunTrust Hold
2020-07-31 繰り返されました Wells Fargo Equal Weight
2020-07-20 アップグレード Credit Suisse Underperform → Neutral
2020-06-03 アップグレード SVB Leerink Mkt Perform → Outperform
2020-05-26 アップグレード SunTrust Sell → Hold
2020-05-01 ダウングレード JP Morgan Overweight → Neutral
2020-05-01 ダウングレード Raymond James Outperform → Mkt Perform
2020-05-01 ダウングレード SunTrust Hold → Sell
2020-04-27 ダウングレード UBS Buy → Neutral
2020-04-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-04-20 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 ダウングレード CFRA Hold → Sell
すべてを表示

Gilead Sciences Inc (GILD) 最新ニュース

pulisher
05:33 AM

A Look at Gilead Sciences Inc (GILD) After 5.2% Gain -- GF Value $96.06 vs Price $136.36 - GuruFocus

05:33 AM
pulisher
04:41 AM

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MSN

04:41 AM
pulisher
10:50 AM

Gilead Sciences rises as analyst upgrade adds to HIV franchise momentum - Quiver Quantitative

10:50 AM
pulisher
10:23 AM

Gilead Sciences keeps building its antiviral pipeline. The focus shifts to long-term growth and US m - AD HOC NEWS

10:23 AM
pulisher
10:03 AM

Gilead Stock Rallies As Trodelvy Wins First-Line Cancer Nod - StocksToTrade

10:03 AM
pulisher
10:00 AM

BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients - GlobeNewswire Inc.

10:00 AM
pulisher
08:57 AM

Truist Securities Adjusts Gilead Sciences Price Target to $156 From $157 - marketscreener.com

08:57 AM
pulisher
08:35 AM

Gilead price tries to pierce ceiling of descending correctional price channelForecast today07-07-2026 - Economies.com

08:35 AM
pulisher
07:27 AM

RBC Capital Adjusts Gilead Sciences Price Target to $120 From $122, Maintains Sector Perform Rating - marketscreener.com

07:27 AM
pulisher
Jul 06, 2026

Gilead Sciences Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jul 06, 2026
pulisher
Jul 06, 2026

GILDGilead Sciences Inc Options - Finviz

Jul 06, 2026
pulisher
Jul 06, 2026

What's Going on With Gilead Sciences Stock Monday?Gilead Sciences (NASDAQ:GILD) - Benzinga

Jul 06, 2026
pulisher
Jul 06, 2026

Gilead Sciences (GILD) Participates in Ebola Treatment Clinical Trial in Congo - GuruFocus

Jul 06, 2026
pulisher
Jul 06, 2026

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More - Yahoo Finance

Jul 06, 2026
pulisher
Jul 06, 2026

This Gilead Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga

Jul 06, 2026
pulisher
Jul 05, 2026

Earnings call transcript: Gilead Sciences beats Q1 2026 forecasts, stock dips - Investing.com

Jul 05, 2026
pulisher
Jul 04, 2026

Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel - The National Law Review

Jul 04, 2026
pulisher
Jul 03, 2026

Insider Sell: Daniel O'Day Sells 15,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus

Jul 03, 2026
pulisher
Jul 03, 2026

Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion -- Update - marketscreener.com

Jul 03, 2026
pulisher
Jul 03, 2026

If You Invested $1000 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today - Sahm

Jul 03, 2026
pulisher
Jul 02, 2026

Gilead Sciences Inc (GILD) Stock Up 4.2% but GF Value Says Overv - GuruFocus

Jul 02, 2026
pulisher
Jul 02, 2026

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Jul 02, 2026
pulisher
Jul 01, 2026

Calvert VP SRI Balanced Portfolio's Gilead Sciences Inc(GILD) Holding History - GuruFocus

Jul 01, 2026
pulisher
Jul 01, 2026

Gilead Owed $68M In Counterfeit Case, Magistrate Judge Says - Law360

Jul 01, 2026
pulisher
Jul 01, 2026

Gilead Sciences highlights its antiviral portfolio as a long-term growth driver - AD HOC NEWS

Jul 01, 2026
pulisher
Jun 30, 2026

List of 21 Acquisitions by Gilead (Jul 2026) - Tracxn

Jun 30, 2026
pulisher
Jun 30, 2026

Morgan Stanley Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $168 - Moomoo

Jun 30, 2026
pulisher
Jun 30, 2026

Gilead Sciences consensus picture, shares steady on NASDAQ - AD HOC NEWS

Jun 30, 2026
pulisher
Jun 30, 2026

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products - WSJ

Jun 30, 2026
pulisher
Jun 29, 2026

Gilead Sciences, Inc.(NasdaqGS: GILD) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Gilead Sciences Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jun 29, 2026
pulisher
Jun 29, 2026

Gilead Sciences Inc (NASDAQ:GILD): A Sustainable Dividend Leader in the Biotechnology Sector - ChartMill

Jun 29, 2026
pulisher
Jun 29, 2026

Gilead Sciences, Inc.(NasdaqGS: GILD) dropped from Russell Top 200 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Gilead Sciences wins Trodelvy approvals, shares supported by oncology focus - AD HOC NEWS

Jun 29, 2026
pulisher
Jun 29, 2026

Gilead Sciences, Inc.(NasdaqGS: GILD) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Gilead Sciences, Inc.(NasdaqGS: GILD) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Gilead Sciences, Inc.(NasdaqGS: GILD) dropped from Russell 1000 Dynamic Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Gilead Sciences launches Trodelvy in TNBC, shares hold near $128 - AD HOC NEWS

Jun 28, 2026
pulisher
Jun 27, 2026

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC - Insider Monkey

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of Gilead Sciences, Inc. – NASDAQ:GILD - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Gilead Sciences Raises Guidance After Results Top Views - WSJ

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to revenue forward of Gilead Sciences, Inc. – NASDAQ:GILD - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Gilead Sciences clears a fresh 12?month high, shares react to new FDA approval - AD HOC NEWS

Jun 27, 2026
pulisher
Jun 27, 2026

Will Trodelvy’s First-Line TNBC Approval Redefine Gilead Sciences’ (GILD) Oncology-Led Investment Narrative? - Yahoo Finance

Jun 27, 2026
pulisher
Jun 26, 2026

Gilead Sciences (GILD) Wins First Line Trodelvy Approval In The US And Europe - Yahoo Finance

Jun 26, 2026
pulisher
Jun 26, 2026

GILD News | GILEAD SCIENCES INC (NASDAQ:GILD) - ChartMill

Jun 26, 2026
pulisher
Jun 26, 2026

Price to book forward of Gilead Sciences, Inc. – NASDAQ:GILD - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to earnings forward of Gilead Sciences, Inc. – NASDAQ:GILD - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Gilead Sciences Inc (GILD) Shares Surge 3.3% -- What GF Score of 75 Tells Investors - GuruFocus

Jun 26, 2026
pulisher
Jun 26, 2026

Gilead Sciences Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Jun 26, 2026
pulisher
Jun 26, 2026

Gilead Sciences, Inc. Actuals & Estimates (VIE:GILD) - TradingView

Jun 26, 2026

Gilead Sciences Inc (GILD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$368.10
price up icon 0.45%
PFE PFE
$24.07
price up icon 1.48%
NVO NVO
$49.64
price up icon 0.77%
AZN AZN
$193.12
price up icon 1.56%
NVS NVS
$157.03
price up icon 0.99%
大文字化:     |  ボリューム (24 時間):